About Lissencephaly type 1 due to doublecortin gene mutation
Lissencephaly type 1 due to doublecortin gene mutation is a rare disease catalogued by Orphanet (ORPHA:2148). It is associated with the DCX gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Lissencephaly type 1 due to doublecortin gene mutation trials.
Search ClinicalTrials.gov for "Lissencephaly type 1 due to doublecortin gene mutation" or filter by Orphanet code ORPHA:2148 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Lissencephaly type 1 due to doublecortin gene mutation trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Lissencephaly type 1 due to doublecortin gene mutation. Updated daily.